# Pharmacosmos

Source: https://onco.cc/companies/pharmacosmos/  
OnCo record `pharmacosmos` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Pharmacosmos is a Danish family-owned company specialising in intravenous iron; its iron isomaltoside (Monofer) treats the anaemia that chemotherapy and cancer itself cause, and it leads phase 3 trials in that setting.

## Summary

Pharmacosmos A/S, founded in 1965 and based in Holbæk, Denmark, develops carbohydrate chemistry and intravenous iron products. Its iron isomaltoside 1000 (Monofer, ferric derisomaltose in the United States) is given as a single high-dose infusion for iron deficiency anaemia, including in patients with cancer, and the company has run phase 3 trials in cancer-related anaemia registered on ClinicalTrials.gov.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Pharmacosmos A/S
- Tags: ctgov-sponsor
- HQ: Holbæk
- Type: pharma
- Website: http://www.pharmacosmos.com

## Sources

- Official website: http://www.pharmacosmos.com
- ClinicalTrials.gov: trials led by Pharmacosmos A/S: https://clinicaltrials.gov/search?lead=Pharmacosmos%20A%2FS
- Wikidata: https://www.wikidata.org/wiki/Q7180808

## Connected records

- fronts: [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/pharmacosmos.json